Uncertainty quantification is the computational discipline that endows a predictive model with the ability to know what it does not know. In molecular property estimation, UQ moves beyond a single-point prediction of solubility or toxicity to provide a calibrated probability distribution. This distribution explicitly partitions the total predictive uncertainty into its two fundamental components: aleatoric uncertainty, the irreducible statistical noise inherent in experimental measurements, and epistemic uncertainty, the reducible ignorance arising from a lack of training data in a specific region of chemical space.
Glossary
Uncertainty Quantification

What is Uncertainty Quantification?
Uncertainty quantification (UQ) is the process of assigning a confidence interval or probability distribution to a model's prediction, rigorously distinguishing between aleatoric uncertainty (inherent data noise) and epistemic uncertainty (model ignorance).
A robust UQ framework is critical for high-stakes decision-making in drug discovery, where a false negative in toxicity screening can halt a program. Techniques such as conformal prediction provide rigorous, finite-sample coverage guarantees by outputting prediction sets rather than single values, while Bayesian neural networks and deep ensembles model epistemic uncertainty by placing distributions over model weights. By flagging predictions with high epistemic uncertainty, UQ directs the next cycle of experimentation, forming the core logic of an active learning loop for molecular design.
Core Components of Uncertainty Quantification
Uncertainty quantification (UQ) in molecular property prediction decomposes a model's total predictive uncertainty into its constituent parts, enabling risk-aware decision-making in drug discovery pipelines.
Aleatoric Uncertainty
The irreducible noise inherent in the data itself, stemming from measurement errors, biological variability, or inherently stochastic processes. This type of uncertainty cannot be reduced by collecting more training data.
- Source: Noisy assay readouts, natural conformational flexibility
- Characteristic: High aleatoric uncertainty persists even with infinite data
- Mitigation: Improve assay quality, model output as a distribution (e.g., predict mean and variance)
- Example: A solubility measurement varying between 45-55 µM across replicate experiments due to pipetting imprecision
Epistemic Uncertainty
The reducible uncertainty arising from the model's lack of knowledge, caused by insufficient training data or an inadequately expressive model architecture. This uncertainty shrinks as more representative data is collected.
- Source: Sparse sampling of chemical space, model misspecification
- Characteristic: High epistemic uncertainty in regions far from training data
- Mitigation: Acquire more data in underrepresented regions, use Bayesian methods
- Example: A model confidently predicting toxicity for a well-studied scaffold but exhibiting high uncertainty for a novel heterocycle outside its applicability domain
Ensemble Methods for UQ
A practical approach that trains multiple independent models with different random initializations or bootstrapped datasets. The variance across ensemble predictions serves as a proxy for epistemic uncertainty.
- Deep Ensembles: Train 5-10 networks from scratch; variance captures model uncertainty
- Monte Carlo Dropout: Apply dropout at inference time to approximate a Bayesian posterior
- Advantage: Simple to implement, no architectural changes required
- Limitation: Computationally expensive, requires storing and running multiple models
Gaussian Process Regression
A non-parametric Bayesian framework that defines a prior distribution over functions and updates it with observed data. GPs naturally provide calibrated predictive distributions with closed-form uncertainty estimates.
- Kernel function: Matérn or RBF kernels encode chemical similarity assumptions
- Output: Full posterior predictive distribution with mean and variance at any point
- Strength: Principled uncertainty that grows with distance from training points
- Challenge: O(n³) computational scaling limits applicability to large datasets without sparse approximations
Conformal Prediction
A distribution-free, model-agnostic framework that wraps any predictor to produce prediction intervals with finite-sample validity guarantees. It requires only a held-out calibration set.
- Guarantee: For a 90% confidence level, the true value falls within the interval at least 90% of the time
- Mechanism: Uses nonconformity scores on calibration data to determine interval widths
- Advantage: No assumptions about data distribution or model architecture
- Application: Regulatory submissions requiring rigorous statistical confidence bounds on ADMET predictions
Bayesian Neural Networks
Neural networks where weights are treated as probability distributions rather than point estimates. Inference yields a posterior distribution over parameters, capturing epistemic uncertainty directly.
- Variational Inference: Approximates the true posterior with a simpler distribution
- Hamiltonian Monte Carlo: Gold-standard sampling method, computationally intensive
- Output: Predictive distribution obtained by marginalizing over weight posteriors
- Trade-off: Theoretically elegant but challenging to scale to large molecular graph networks
Frequently Asked Questions
Addressing the most common questions about distinguishing between aleatoric and epistemic uncertainty, and applying rigorous confidence measures to molecular property predictions.
Uncertainty Quantification (UQ) is the process of assigning a confidence interval, variance, or full probability distribution to a model's prediction, rather than providing a single point estimate. In the context of molecular property prediction, a model does not just output 'LogP = 2.5'; it outputs 'LogP = 2.5 ± 0.3'. This distinction is critical for risk assessment in drug discovery, allowing a research team to differentiate between a high-confidence prediction suitable for automated triage and a low-confidence prediction that requires expensive wet-lab validation. UQ decomposes total predictive uncertainty into two distinct sources: aleatoric uncertainty, the irreducible noise inherent in the data itself, and epistemic uncertainty, the reducible ignorance stemming from a lack of knowledge or training data in a specific region of chemical space.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Aleatoric vs. Epistemic Uncertainty
A comparative breakdown of the two fundamental types of uncertainty encountered in molecular property prediction, distinguishing inherent data noise from model ignorance.
| Feature | Aleatoric Uncertainty | Epistemic Uncertainty |
|---|---|---|
Definition | Uncertainty inherent in the data generation process itself; statistical noise that cannot be reduced by collecting more samples from the same distribution. | Uncertainty stemming from the model's ignorance about the true underlying function; reducible by gathering more training data or refining the model architecture. |
Alternative Name | Data Uncertainty / Irreducible Noise | Model Uncertainty / Reducible Uncertainty |
Source | Stochasticity in experimental measurements, biological variability, or inherent molecular randomness. | Limited training data, incomplete coverage of chemical space, or model misspecification. |
Reducibility | ||
Dependence on Training Set Size | Constant; remains unchanged regardless of dataset volume. | Decreases asymptotically as the training set grows and covers the applicable domain. |
Primary Mitigation Strategy | Model the output as a probability distribution (e.g., predict a mean and variance) rather than a point estimate. | Active learning, Bayesian inference, ensemble methods, or expanding the training dataset with diverse molecular structures. |
Behavior at a Novel Scaffold | Low to moderate; reflects only the inherent assay noise. | High; the model recognizes it is operating outside its applicability domain and expresses high predictive variance. |
Mathematical Formalization | Captured by the variance term in a heteroscedastic loss function (e.g., Gaussian Negative Log-Likelihood). | Captured by the variance of predictions across an ensemble of models or the posterior distribution in a Bayesian neural network. |
UQ Methods in Molecular Property Prediction
A systematic breakdown of the primary computational strategies used to assign confidence intervals, probability distributions, and prediction sets to machine learning outputs in drug discovery, distinguishing between data noise and model ignorance.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us